Navigation Links
Proscia Takes Aim at Cancer with Artificial Intelligence and Digital Pathology Software
Date:7/26/2017

Proscia Inc., a software solutions provider for digital pathology, announced today its CEO David West Jr. will be a featured panelist at 2017 MedCity CONVERGE. His talk, “The Davids vs. the Cancer Goliath,” will discuss how Proscia and other leading startups in the diagnostics, biopharmaceuticals, medical technology, and emerging technology (AI, VR, Big Data) sectors are taking aim at cancer diagnosis and research. Proscia will also be featured as part of the “Startup Showcase” to further demonstrate the capabilities of its digital pathology software and image analysis algorithms. MedCity CONVERGE will take place on July 31 – August 1, 2017 in Philadelphia, Pennsylvania.

“We are honored to partake in thought-provoking discussions on how innovation in science and technology can take on one of healthcare’s greatest challenges, cancer,” said West. “At Proscia we are committed to developing digital pathology software that will bring cancer diagnosis and research out of the Stone Age and into the digital realm, and ultimately allow pathologists to make more informed diagnoses and improve patient outcomes.”

MedCity CONVERGE  is a two-day executive summit that gathers innovative thought leaders from across all healthcare sectors to provide actionable insight on where medical innovation is heading. This year, MedCity CONVERGE focuses on one of healthcare’s greatest challenges: cancer. Technology disruptors, along with payers, providers, life science companies, and venture capitalists, will all gather to discuss how AI, Big Data and Precision Medicine are changing the game in cancer. The MedCity CONVERGE Startup Showcase features companies taking some of the most innovative approaches and/or trying to solve some of the biggest problems in healthcare.

“Proscia is building software that will augment the work of the pathologist through deep learning and image-based diagnostics, which will revolutionize the way that the field treats cancer,” West adds. “Our goal is to educate leaders in the healthcare sector on ways they can take advantage of our groundbreaking software to more efficiently run their labs.”

About Proscia
Proscia was founded in 2014 by a team out of Johns Hopkins, the Moffitt Cancer Center, and the University of Pittsburgh to improve clinical outcomes and accelerate the discovery of breakthrough advancements in the fight against cancer. Using modern computing technologies that unlock hidden data not visible to the human eye and turning that data into valuable insights in the fight against cancer, the company is dedicated to improving the efficiency, speed, and quality of pathology diagnostics and research. To learn more, please visit http://www.proscia.com.

Read the full story at http://www.prweb.com/releases/2017/07/prweb14537756.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Proscia’s Artificial Intelligence to Transform Pathology Labs and Drive Their Digital Evolution
2. Frost & Sullivan Identifies Proscia as a Game-changing Company in Cloud-based Digital Pathology
3. Proscia Takes on Subjectivity in Pathology Through AI Innovation
4. Proscia and Huron Digital Pathology Partner to Provide Seamlessly Integrated Digital Pathology Scanner-Software Solution
5. Proscia Partners with Samsung Medical Center to Research Predictive Medicine in Cancer Diagnosis and Treatment
6. Proscia Announces Massive Dataset Migration Service to Accelerate Transfer of Large-Scale Digital Pathology Image Data to the Cloud
7. American Diabetes Association Takes An Ostrich Approach to Brittle Diabetes
8. Sigma Blood Systems CEO Max Doleh Takes Message on Value of Quality and Process Management Software to Global Audiences
9. Electronic Data Capture System ClinCapture Takes Home Two Bronze Stevie Awards for Best New Product of The Year 2016
10. Stockton Takes First Step Into The U.S. Market
11. Ping An Ventures Takes Equity Stake in 20/20 GeneSystems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2019)... City, California (PRWEB) , ... ... ... allowance of our patent applications from the USPTO providing proprietary interest to ... AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights ...
(Date:5/31/2019)... ... May 30, 2019 , ... Object Pharma, ... the strategic acquisition of Metabiologics, Inc., a globally recognized leader in the production ... and commercialization rights to a full spectrum of botulinum neurotoxins, as well as ...
(Date:5/22/2019)... ... ... Artemis (formerly Agrilyst), the leading enterprise Cultivation Management Platform (CMP), ... Astanor Ventures and Talis Capital with participation from existing investors ... The company has raised $11.75m to date and will use the new funding to ...
(Date:5/15/2019)... ... , ... Milton Hershey School® has named William Charles Ballough Harding ’78 the ... where he is changing lives by creating solutions to global healthcare challenges through the ... of our founders – Milton and Catherine Hershey – who always hoped for Milton ...
Breaking Biology Technology:
(Date:5/31/2019)... ... May 30, 2019 , ... ... in a live webinar on Wednesday, June 19, 2019 at 1pm ... teams, medical review teams, data management teams and contract research organizations (CROs) can ...
(Date:5/31/2019)... ... May 31, 2019 , ... The OilComm Conference & Exposition, ... today that Ben Reiter, Senior Writer at Sports Illustrated and Author of Astroball, ... Reiter predicted the Houston Astros would win the MLB championship in 2014 when ...
(Date:5/24/2019)... ... May 24, 2019 , ... The newest edition of ... now available on the company’s global website. , Crystallography Times is a monthly electronic ... diffraction. It serves the X-ray analysis community by presenting the latest news and crystallographic ...
Breaking Biology News(10 mins):